Literature DB >> 5439551

[The treatment of parkinsonism with amantadine].

G W Völler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5439551     DOI: 10.1055/s-0028-1108565

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  7 in total

1.  Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Authors:  N Callagham; M Mcllroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

Review 2.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

3.  On the effect of amantadine on ATP content and ATPase activity in brain and blood of rats.

Authors:  V A Velkov
Journal:  Experientia       Date:  1974-04-15

4.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

5.  Failure of amantadine to modify serum growth hormone and insulin levels.

Authors:  F Cavagnini; A E Pontiroli; U Raggi; M Peracchi; A Malinverni
Journal:  Experientia       Date:  1973-05-15

6.  Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations.

Authors:  M Brenner; A Haass; P Jacobi; K Schimrigk
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

7.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.